XML 45 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock Compensation Expense
Stock compensation consisted of the following:
 
Years Ended December 31,
 
2017
 
2016
 
 
(In millions)
Stock compensation expense
$
(0.1
)
 
$
0.8

 
Schedule of Weighted Average Assumptions Used in the Valuation of Options
The following table summarizes our weighted average assumptions used in the valuation of options for the years ended December 31. There were no stock options granted in 2017.
 
2017
 
2016
 
Volatility
N/A
 
44
%
 
Risk-free interest rate
N/A
 
1.55
%
 
Expected life (months)
N/A
 
72

 
Dividend yield
N/A
 
—
%
 
Schedule of Stock Option Activity
The following table summarizes our stock option activity:
 
Stock Options
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Life (Years)
Outstanding December 31, 2015
455,122

 
$
90.22

 
4.4
Granted
(4,500
)
 
8.30

 
 
Exercised
(722
)
 
14.00

 
 
Canceled
(116,843
)
 
158.77

 
 
Forfeited
(46,350
)
 
14.93

 
 
Outstanding December 31, 2016
286,707

 
$
77.51

 
3.8
Granted
—

 
—

 
 
Exercised
—

 
—

 
 
Canceled
(71,400
)
 
80.23

 
 
Forfeited
(25,841
)
 
16.42

 
 
Outstanding December 31, 2017
189,466

 
$
84.81

 
1.8
Exercisable as of December 31, 2017
183,466

 
$
87.12

87.12

1.6
Schedule of Restricted Stock Activity
The following table summarizes our restricted stock activity:
 
Restricted Stock
 
Weighted Average Grant Date Fair Value Per Share
Nonvested as of December 31, 2015
116,278

 
$
23.36

Granted
7,730

 
5.30

Vested
(34,310
)
 
23.82

Forfeited
(9,773
)
 
25.51

Nonvested as of December 31, 2016
79,925

 
$
20.64

Granted
206,666

 
3.36

Vested
(5,404
)
 
10.00

Forfeited
(67,205
)
 
22.84

Nonvested as of December 31, 2017
213,982

 
$
3.53
Schedule of Stock Appreciation Rights (SARs)
The following table summarizes our stock appreciation rights activity:
 
Stock Appreciation Rights
Outstanding as of December 31, 2015
379,495

Granted
—

Canceled
(169,533
)
Outstanding as of December 31, 2016
209,962

Granted
—

Canceled
(138,526
)
Outstanding as of December 31, 2017
71,436